Pacific Biosciences of California, Inc.
PACB- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001299130
In the last 90 days, Pacific Biosciences of California, Inc. insiders filed 0 open-market purchases and 1 sale; 223 institutions reported holding it in 13F filings for Q2 2026, worth $320.8M in total; superinvestors ARK Invest and HHLR Advisors (Hillhouse) hold it.
13F holders, Q4 2024
Institutional positions in Pacific Biosciences of California, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 227
- +5 vs. Q3 2024
- Shares held
- 259.5M
- +27.7M (+12.0%) vs. Q3 2024
- Total value
- $475.1M
- +$81.0M (+20.6%) vs. Q3 2024
- New holders
- 39
- 75 more added
- Sold out
- 34
- 65 more reduced
4 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PACB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 223 | $320.8M |
| Q1 2026 | 231 | $248.5M |
| Q4 2025 | 216 | $373.5M |
| Q3 2025 | 208 | $237.8M |
| Q2 2025 | 207 | $245.8M |
| Q1 2025 | 225 | $265.6M |
| Q4 2024 | 227 | $475.1M |
| Q3 2024 | 226 | $394.3M |
| Q2 2024 | 229 | $331.9M |
| Q1 2024 | 268 | $1.01B |
| Q4 2023 | 274 | $2.76B |
| Q3 2023 | 275 | $2.20B |
| Q2 2023 | 272 | $3.37B |
| Q1 2023 | 260 | $2.93B |
| Q4 2022 | 237 | $1.84B |
| Q3 2022 | 227 | $1.23B |
| Q2 2022 | 230 | $1.03B |
| Q1 2022 | 250 | $2.03B |
| Q4 2021 | 256 | $4.20B |
| Q3 2021 | 246 | $4.83B |
| Q2 2021 | 261 | $6.04B |
| Q1 2021 | 263 | $5.47B |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Pacific Biosciences of California, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Senvest Management, LLC | 1,093,954 | $2.00M | 0.06% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 1,113,577 | $2.04M | 0.00% | +648,407+139.4% | Added |
| UBS Group AG | 1,486,015 | $2.72M | 0.00% | +843,166+131.2% | Added |
| Barclays PLC | 1,660,059 | $3.04M | 0.00% | +1,064,909+178.9% | Added |
| Price T Rowe Associates Inc | 1,771,653 | $3.24M | 0.00% | −67,099−3.6% | Reduced |
| Walleye Capital LLC | 1,943,046 | $3.56M | 0.03% | +1,698,931+696.0% | Added |
| Koss-Olinger Consulting, LLC | 2,000,000 | $3.66M | 0.32% | +1,200,000+150.0% | Added |
| Charles Schwab Investment Management Inc | 2,176,252 | $3.98M | 0.00% | +135,949+6.7% | Added |
| Bank of America Corp | 2,214,513 | $4.05M | 0.00% | −139,334−5.9% | Reduced |
| Soros Fund Management LLCSuperinvestorSoros Fund Management | 2,372,265 | $4.34M | 0.08% | +274,265+13.1% | Added |
| Northern Trust Corp | 2,514,824 | $4.60M | 0.00% | +157,145+6.7% | Added |
| Goldman Sachs Group Inc | 4,792,776 | $8.77M | 0.00% | +554,509+13.1% | Added |
| T. Rowe Price Investment Management, Inc. | 4,896,844 | $8.96M | 0.01% | +4,896,844 | New |
| Jackson Square Partners, LLC | 5,109,266 | $9.35M | 1.01% | −1,186,850−18.9% | Reduced |
| Bank of New York Mellon Corp | 5,203,967 | $9.52M | 0.00% | −369,200−6.6% | Reduced |
| Morgan Stanley | 5,651,558 | $10.3M | 0.00% | +1,759,016+45.2% | Added |
| Geode Capital Management, LLC | 6,262,925 | $11.5M | 0.00% | −64,981−1.0% | Reduced |
| State Street Corp | 6,426,975 | $11.8M | 0.00% | +150,819+2.4% | Added |
| Nikko Asset Management Americas, Inc. | 10,178,501 | $18.4M | 0.20% | −1,687,265−14.2% | Reduced |
| Sumitomo Mitsui Trust Holdings, Inc. | 10,178,501 | $18.6M | 0.01% | −1,687,265−14.2% | Reduced |
| Vanguard Group Inc | 15,226,858 | $27.9M | 0.00% | −2,415,946−13.7% | Reduced |
| Millennium Management LLC | 17,065,331 | $31.2M | 0.03% | +6,642,753+63.7% | Added |
| Softbank Group Corp | 20,451,570 | $37.4M | 0.16% | +20,451,570 | New |
| Edmond de Rothschild Holding S.A. | 21,346,480 | $39.1M | 0.67% | +1,038,600+5.1% | Added |
| Madrone Advisors, LLC | 23,391,915 | $42.8M | 8.16% | 00.0% | Unchanged |
| BlackRock, Inc. | 24,594,773 | $45.0M | 0.00% | +1,342,091+5.8% | Added |
| ARK Investment Management LLCSuperinvestorARK Invest | 36,044,362 | $66.0M | 0.55% | +2,637,961+7.9% | Added |
| Proequities, Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Capital World Investors | 0 | $0 | 0.00% | −3,390,000−100.0% | Sold out |
| VK Services, LLC | 0 | $0 | 0.00% | −1,316,393−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −655,885−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −213,900−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −192,956−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −78,171−100.0% | Sold out |
| Exome Asset Management LLC | 0 | $0 | 0.00% | −75,300−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −56,861−100.0% | Sold out |
| Ci Investments Inc. | 0 | $0 | 0.00% | −42,018−100.0% | Sold out |
| Ethic Inc. | 0 | $0 | 0.00% | −17,383−100.0% | Sold out |
| Paloma Partners Management Co | 0 | $0 | 0.00% | −36,901−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −27,752−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −27,438−100.0% | Sold out |
| Sandbox Financial Partners, LLC | 0 | $0 | 0.00% | −24,000−100.0% | Sold out |
| HarbourVest Partners LLC | 0 | $0 | 0.00% | −23,484−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −23,358−100.0% | Sold out |
| Veriti Management LLC | 0 | $0 | 0.00% | −22,816−100.0% | Sold out |
| Toroso Investments, LLC | 0 | $0 | 0.00% | −21,358−100.0% | Sold out |
| GTS Securities LLC | 0 | $0 | 0.00% | −20,188−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −17,605−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −16,800−100.0% | Sold out |
| Westmount Partners, LLC | 0 | $0 | 0.00% | −15,500−100.0% | Sold out |
| Bleakley Financial Group, LLC | 0 | $0 | 0.00% | −14,389−100.0% | Sold out |
| Water Island Capital LLC | 0 | $0 | 0.00% | −14,000−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −13,310−100.0% | Sold out |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −13,130−100.0% | Sold out |
| Atria Wealth Solutions, Inc. | 0 | $0 | 0.00% | −11,806−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −11,407−100.0% | Sold out |
| Kayne Anderson Rudnick Investment Management LLC | 0 | $0 | 0.00% | −7,046−100.0% | Sold out |
| Dynamic Wealth Strategies, LLC | 0 | $0 | 0.00% | −1,678−100.0% | Sold out |
| Picton Mahoney Asset Management | 0 | $0 | 0.00% | −1,441−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −1,033−100.0% | Sold out |
| Jaffetilchin Investment Partners, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Raymond James & Associates | – | – | – | – | Not filed |
| Abich Financial Wealth Management LLC | – | – | – | – | Not filed |
| FinTrust Capital Advisors, LLC | – | – | – | – | Not filed |
| Planning Capital Management Corp | – | – | – | – | Not filed |